Patent holdings for IPC class C07D 281/10

Total number of patents in this class: 141

10-year publication summary

12
6
1
9
9
13
16
12
8
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Albireo AB
170
31
Elobix AB
17
15
Glaxosmithkline Intellectual Property (no.2) Limited
287
9
RyCarma Therapeutics, Inc.
23
9
Armgo Pharma, Inc.
13
8
Glaxosmithkline Intellectual Property Development Limited
761
7
Shire Human Genetic Therapies, Inc.
190
5
VALO Health, Inc.
172
3
Novartis AG
10829
2
Glaxosmithkline LLC
536
2
Merck Sharp & Dohme Corp.
2190
2
Apeiron Biologics AG
32
2
Assembly Biosciences, Inc.
77
2
KYORIN Pharmaceutical Co., Ltd.
167
2
Les Laboratoires Servier
540
2
Shanghai Institute of Pharmaceutical Industry
129
2
HK Inno.n Corporation
108
2
Shanghai Zhongze Therapeutics, Co. Ltd.
5
2
Hainan Jin Rui Pharmaceutical Co., Ltd.
8
2
Bristol-myers Squibb Company
4884
1
Other owners 31